Hims & Hers Health Financial Ratios
NYSE: HIMSHealthcareDrug Manufacturers - Specialty & GenericUSD
30.92+2.86 (+10.19%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Hims & Hers Health ratio analysis
Hims & Hers Health earned a net margin of 5.5% in FY 2025, down from 8.5% a year earlier. Gross margin was 73.8% compared with a median of 76.4% over the prior 6 years. Return on equity reached 23.7%, meaning Hims & Hers Health generated 0.24 dollars of profit for every dollar of shareholders' equity.
Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Hims & Hers Health financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 65.51 | 50.25 | — | — | — | — | — |
| Price / sales | 3.20 | 3.89 | 2.14 | 2.49 | 4.50 | 3.47 | 4.17 |
| Price / book | 13.89 | 12.06 | 5.42 | 4.21 | 3.66 | — | — |
| Gross margin | 73.8% | 79.5% | 82.0% | 77.6% | 75.2% | 73.6% | 54.0% |
| Operating margin | 4.5% | 4.2% | -3.4% | -13.0% | -42.3% | -10.2% | -90.1% |
| Net margin | 5.5% | 8.5% | -2.7% | -12.5% | -39.6% | -12.2% | -87.3% |
| Free cash flow margin | 2.4% | 13.4% | 5.4% | -6.4% | -12.7% | -1.7% | -90.7% |
| Return on equity (ROE) | 23.7% | 26.4% | -6.8% | -21.1% | -32.2% | — | — |
| Return on assets (ROA) | 6.0% | 17.8% | -5.3% | -17.9% | -25.6% | -15.3% | -35.2% |
| Current ratio | 1.90 | 1.79 | 3.00 | 4.52 | 3.41 | 7.43 | 1.69 |
| Revenue growth | 59.0% | 69.3% | 65.5% | 93.8% | 82.8% | 80.2% | — |
| EPS growth | -3.8% | — | — | — | — | — | — |